Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urinary Tract Infections 1 Urinary Bladder Neoplasms 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Exanthema 1 Colorectal Neoplasms 1

Interventions

dexpanthenol 1 Triamcinolone Acetonide 1 Tetracycline 1 Provitamins 1 Prednisone 1 Panitumumab 1 Minocycline 1 Irinotecan 1 IFL protocol 1 Hydrocortisone 1 Gels 1 Erlotinib Hydrochloride 1 Doxycycline 1 Dapsone 1 Clindamycin 1 Anti-Bacterial Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Exanthema × Clindamycin × Clear all

NCT00473083 2017-04-04

LUTRAERL

British Columbia Cancer Agency

Phase 2 Completed

150 enrolled 13 charts

Exanthema, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡